08048035996
Diabetes RYBELSUS 14mg Tablets trusted to Canada - Toronto | Phoenix Exim | Global Exporter

1. General Information

Rybelsus 14 mg Tablets contain semaglutide 14 mg, an oral glucagon-like peptide-1 (GLP-1) receptor agonist. It is a prescription medicine used together with diet and exercise to improve blood-glucose control in adults with inadequately controlled type 2 diabetes mellitus. Rybelsus is manufactured by Novo Nordisk.

Phoenix Exim, based in Nagpur, India, deals in pharmaceutical products for international markets including the USA, UK, Australia, Singapore, Canada, South Korea and UAE, subject to applicable import and regulatory requirements.

Important: Rybelsus is a prescription medicine. It should be used only under the supervision of a qualified healthcare professional.


2. Product Information

ProductRybelsus 14 mg Tablets
Active IngredientSemaglutide
Strength14 mg
Dosage FormTablet
RouteOral
Drug ClassGLP-1 receptor agonist
Therapeutic AreaType 2 Diabetes
ATC CodeA10BJ06
ManufacturerNovo Nordisk
Prescription StatusPrescription medicine

The 14 mg tablet contains 14 mg of semaglutide and is intended for oral administration. Official product information lists Rybelsus in 3 mg, 7 mg and 14 mg strengths.


3. Uses of Rybelsus 14 mg

Rybelsus is primarily used to:

  • Improve blood-glucose control in adults with type 2 diabetes mellitus.
  • Be used alongside appropriate diet and physical activity.
  • Be used alone when metformin is inappropriate because of intolerance or contraindications.
  • Be combined with other diabetes medicines when additional glucose control is required.

Rybelsus is not indicated for treating type 1 diabetes.


4. Benefits of Rybelsus 14 mg

Potential therapeutic benefits include:

  • Helps improve blood-glucose control.
  • Helps reduce HbA1c in adults with type 2 diabetes.
  • Can be used as an oral GLP-1 receptor agonist rather than an injectable GLP-1 medicine.
  • Clinical studies have demonstrated improvements in glycaemic control.
  • Treatment has also been associated with reductions in body weight in clinical studies.

The degree of benefit varies between individuals and depends on the treatment plan, diet, physical activity and other medicines being used.


5. Side Effects of Rybelsus 14 mg

Like other medicines, Rybelsus can cause side effects. Gastrointestinal effects are particularly common.

Important potential adverse effects include:

  • Nausea
  • Diarrhoea
  • Vomiting
  • Abdominal pain
  • Constipation
  • Decreased appetite
  • Hypoglycaemia, particularly when used with insulin or certain insulin-releasing medicines
  • Pancreatitis
  • Complications related to diabetic retinopathy
  • Serious allergic reactions

The U.S. prescribing information also contains a boxed warning concerning thyroid C-cell tumors observed in rodents; Rybelsus is contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).


6. Common Side Effects

Commonly reported side effects include:

  1. Nausea
  2. Diarrhoea
  3. Vomiting
  4. Abdominal discomfort or pain
  5. Constipation
  6. Reduced appetite

Nausea and diarrhoea are among the most frequently reported adverse effects. Low blood sugar is particularly relevant when Rybelsus is used together with insulin or a sulfonylurea.

If severe or persistent symptoms occur, the patient should contact their healthcare professional.


7. How to Use Rybelsus 14 mg

Rybelsus should be taken exactly as prescribed by a doctor.

For the U.S. dosing regimen, patients generally begin with a lower dose and gradually increase the dose. The 14 mg dose may be used after at least 30 days on 7 mg when additional glycaemic control is required.

Important administration instructions include:

  • Take the tablet once daily.
  • Take it on an empty stomach when first getting up.
  • Take it with no more than 4 ounces (approximately 120 mL) of plain water.
  • Wait at least 30 minutes before eating, drinking other beverages or taking other oral medicines.
  • Swallow the tablet whole.
  • Do not crush, split or chew the tablet.

Do not start or increase to 14 mg without medical advice.


8. How Rybelsus Works

Rybelsus contains semaglutide, which is a GLP-1 receptor agonist.

Semaglutide acts similarly to the naturally occurring GLP-1 hormone. It helps increase insulin secretion from the pancreas when blood glucose is elevated and reduces glucagon secretion. These actions help improve blood-glucose regulation.

It can also influence appetite and food intake, which contributes to the weight reduction observed in clinical studies.


9. Safety Advice for Rybelsus 14 mg

Before using Rybelsus, patients should inform their healthcare professional about their medical history and all medicines they take.

Important precautions:

  • Do not use if there is a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2.
  • Do not use in patients with a serious previous hypersensitivity reaction to semaglutide or its ingredients.
  • Tell your doctor if you have a history of pancreatitis.
  • Patients with diabetic retinopathy may require appropriate monitoring.
  • Hypoglycaemia risk can increase when Rybelsus is combined with insulin or insulin secretagogues.
  • Inform your healthcare professional before surgery or procedures requiring general anaesthesia or deep sedation.
  • Follow the prescribed dose and administration instructions carefully.
  • Keep the medicine away from children.
  • Do not share prescription medicine with another person.

Seek urgent medical attention for symptoms suggestive of severe allergic reaction, severe abdominal pain that may indicate pancreatitis, or other serious unexpected reactions.


10. Frequently Asked Questions (FAQs)

Q1. What is Rybelsus 14 mg?

Rybelsus 14 mg is an oral tablet containing 14 mg of semaglutide, a GLP-1 receptor agonist used to improve blood-glucose control in adults with type 2 diabetes.

Q2. What is the active ingredient in Rybelsus?

The active ingredient is semaglutide.

Q3. Is Rybelsus 14 mg used for diabetes?

Yes. It is indicated for improving glycaemic control in adults with inadequately controlled type 2 diabetes, together with diet and exercise.

Q4. Is Rybelsus an injection?

No. Rybelsus is an oral tablet. Semaglutide is also available in other medicines and dosage forms, but Rybelsus itself is taken by mouth.

Q5. Can Rybelsus 14 mg be taken with food?

It should be taken on an empty stomach with a small amount of plain water, and the patient should wait at least 30 minutes before eating or drinking other beverages.

Q6. Can Rybelsus cause nausea?

Yes. Nausea is one of the most common side effects associated with Rybelsus.

Q7. Can Rybelsus help with weight loss?

Weight reduction has been observed in clinical studies, but Rybelsus is indicated primarily for glycaemic control in type 2 diabetes.

Q8. Can everyone take Rybelsus 14 mg?

No. It is prescription medicine and may not be appropriate for everyone. A healthcare professional should assess the patient's medical history, current medicines and treatment needs.

Q9. Is Rybelsus 14 mg available in Singapore?

Rybelsus 14 mg is listed by Singapore's National Drug Formulary as a prescription-only medicine containing semaglutide 14 mg.

Q10. Who should decide the appropriate Rybelsus dose?

A qualified healthcare professional should determine the appropriate dose and whether the 14 mg strength is suitable.


11. Substitute / Alternatives for Rybelsus

The appropriate substitute depends on the patient's diagnosis, treatment history, glucose levels, other medicines and medical conditions. A substitute should not be selected solely on the basis of the same active ingredient or dose.

Possible therapeutic alternatives may include other GLP-1 receptor agonists or other classes of type 2 diabetes medicines. Injectable semaglutide products such as Ozempic are not automatically interchangeable with Rybelsus because they have different formulations, routes of administration and dosing schedules.

A doctor or pharmacist should determine the most appropriate alternative.


12. SEO Keywords

Primary keywords:

  • Rybelsus 14 mg Tablets
  • Rybelsus 14 mg exporter
  • Rybelsus 14 mg supplier from India
  • Rybelsus 14 mg pharmaceutical exporter
  • Semaglutide 14 mg Tablets
  • Semaglutide 14 mg supplier
  • Rybelsus Tablets exporter India
  • Rybelsus 14 mg medicine exporter
  • Rybelsus 14 mg wholesale supplier
  • Rybelsus 14 mg international supplier

Long-tail B2B keywords:

  • Rybelsus 14 mg Tablets exporter from Nagpur India
  • Genuine Rybelsus 14 mg Tablets pharmaceutical supplier from India
  • Rybelsus 14 mg Semaglutide Tablets wholesale exporter
  • Rybelsus 14 mg Tablets supplier for international pharmaceutical buyers
  • Semaglutide 14 mg Tablets exporter from India
  • Rybelsus 14 mg pharmaceutical products supplier India
  • Rybelsus 14 mg Tablets exporter to USA
  • Rybelsus 14 mg Tablets exporter to UK
  • Rybelsus 14 mg Tablets exporter to Australia
  • Rybelsus 14 mg Tablets exporter to Singapore
  • Rybelsus 14 mg Tablets exporter to Canada
  • Rybelsus 14 mg Tablets exporter to South Korea
  • Rybelsus 14 mg Tablets exporter to UAE
  • Trusted pharmaceutical exporter from Nagpur India
  • Rybelsus 14 mg international medicine supplier
  • Semaglutide Tablets pharmaceutical exporter India
  • Rybelsus 14 mg prescription medicine supplier
  • Rybelsus 14 mg diabetes medicine exporter
  • Rybelsus 14 mg tablets wholesale pharmaceutical supplier
  • Rybelsus semaglutide tablets global pharmaceutical supply
Aug 21st, 2026 12:57 PM

Keywords